Insider Trading History of Wagner Paul A.

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Wagner Paul A. since 2020. This trader's CIK number is 1612842. At the time of last reporting, Wagner Paul A. was the SEE REMARKS of Forte Biosciences, Inc.. (stock ticker symbol FBRX). Also see all insider trading activities at Forte Biosciences, Inc..


Yearly summary of insider trading at Forte Biosciences, Inc. (FBRX) by Wagner Paul A.

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 FBRX 0 $0 0 $0 2,500 $0
2024 FBRX 0 $0 0 $0 95,000 $0
2023 FBRX 118,865 $75,032 0 $0 93,750 $0
2021 FBRX 0 $0 1,000,000 $4,347,000 0 $0
2020 FBRX 7,000 $101,353 0 $0 0 $0


Insider trading of Forte Biosciences, Inc. (FBRX) by Wagner Paul A.

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-07-01 FBRX Option Ex 1,250 .00 0
2025-04-01 FBRX Option Ex 1,250 .00 0
2024-10-01 FBRX Option Ex 1,250 .00 0
2024-07-01 FBRX Option Ex 31,250 .00 0
2024-04-01 FBRX Option Ex 31,250 .00 0
2024-01-01 FBRX Option Ex 31,250 .00 0
2023-12-18 FBRX Buy 10,000 .75 7,530
2023-12-13 FBRX Buy 10,520 .70 7,353
2023-12-14 FBRX Buy 10,000 .72 7,200
2023-12-11 FBRX Buy 25,000 .65 16,200
2023-12-12 FBRX Buy 4,776 .65 3,090
2023-12-07 FBRX Buy 36,203 .58 21,178
2023-12-08 FBRX Buy 15,000 .62 9,300
2023-11-20 FBRX Buy 6,966 .43 3,009
2023-11-22 FBRX Buy 400 .43 172
2023-10-01 FBRX Option Ex 31,250 .00 0
2023-07-01 FBRX Option Ex 31,250 .00 0
2023-04-01 FBRX Option Ex 31,250 .00 0
2021-09-07 FBRX Sale 1,000,000 4.35 4,347,000
2020-06-25 FBRX Buy 7,000 14.48 101,353

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wagner Paul A. (SEE REMARKS of Forte Biosciences, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.